CME Group (CME) – Analysts’ Weekly Ratings Changes

by · The Markets Daily

A number of firms have modified their ratings and price targets on shares of CME Group (NASDAQ: CME) recently:

  • 12/17/2025 – CME Group had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $310.00 to $318.00. They now have a “buy” rating on the stock.
  • 12/12/2025 – CME Group had its price target raised by analysts at Barclays PLC from $280.00 to $304.00. They now have an “equal weight” rating on the stock.
  • 12/10/2025 – CME Group had its price target raised by analysts at Bank of America Corporation from $201.00 to $209.00.
  • 12/5/2025 – CME Group had its price target raised by analysts at Royal Bank Of Canada from $282.00 to $295.00. They now have a “sector perform” rating on the stock.
  • 12/4/2025 – CME Group had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $264.00 to $263.00. They now have a “sell” rating on the stock.
  • 11/25/2025 – CME Group had its price target raised by analysts at The Goldman Sachs Group, Inc. from $263.00 to $264.00. They now have a “sell” rating on the stock.
  • 11/14/2025 – CME Group had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $300.00 to $310.00. They now have a “buy” rating on the stock.
  • 11/13/2025 – CME Group had its price target raised by analysts at Piper Sandler from $296.00 to $313.00. They now have an “overweight” rating on the stock.
  • 11/6/2025 – CME Group had its price target raised by analysts at Rothschild & Co Redburn from $297.00 to $300.00. They now have a “neutral” rating on the stock.
  • 10/31/2025 – CME Group had its price target lowered by analysts at Argus from $308.00 to $295.00.
  • 10/23/2025 – CME Group had its price target lowered by analysts at UBS Group AG from $285.00 to $280.00. They now have a “neutral” rating on the stock.
  • 10/23/2025 – CME Group had its price target raised by analysts at Morgan Stanley from $312.00 to $314.00. They now have an “overweight” rating on the stock.
  • 10/23/2025 – CME Group had its price target raised by analysts at The Goldman Sachs Group, Inc. from $262.00 to $263.00. They now have a “sell” rating on the stock.
  • 10/23/2025 – CME Group had its price target raised by analysts at TD Cowen from $288.00 to $290.00. They now have a “hold” rating on the stock.
  • 10/23/2025 – CME Group was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “buy” rating. They now have a $300.00 price target on the stock, up previously from $266.00.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th will be paid a dividend of $1.25 per share. The ex-dividend date is Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s payout ratio is presently 48.45%.

Insider Activity at CME Group

In other CME Group news, Director Harold Eugene Jr. Ford sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total transaction of $263,530.00. Following the transaction, the director owned 1,091 shares in the company, valued at approximately $287,511.23. This represents a 47.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Terrence A. Duffy sold 25,000 shares of the firm’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the transaction, the chief executive officer directly owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. This represents a 27.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 26,392 shares of company stock worth $7,104,984. 0.30% of the stock is owned by insiders.

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also